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Xenograft bone substitutes, such as deproteinized bovine bone mineral (DBBM), have been widely
employed as osteoconductive structural materials for bone tissue engineering. However, the loss of
xenograft bone substitute particles in defects has been a major limitation, along with a lack of
osteoinductive function. Mussel adhesive protein (MAP), a remarkable and powerful adhesive biomaterial
in nature, can attach to various substrates, even in wet environments. Its adhesive and water-resistant
abilities are considered to be mainly derived from the reduced catechol form, 3,4-
dihydroxyphenylalanine (DOPA), of its tyrosine residues. Here, we evaluated the use of DOPA-containing
MAP as a functional binder biomaterial to eﬀectively retain DBBM particles at the defect site during in
vivo bone regeneration. We observed that DOPA-containing MAP was able to bind DBBM particles easily
to make an aggregate, and grafted DBBM particles were not lost in a defect in the rat calvaria during the
healing period. Importantly, grafting of a DOPA-containing MAP-bound DBBM aggregate resulted in
remarkably accelerated in vivo bone regeneration and even bone remodeling. Interestingly, we found
that the DOPA residues in the modiﬁed MAP had an osteoinductive ability based on clear observation of
the in vivo maturation of new bones with a similar bone density to the normal bone and of the in vitro
osteogenic diﬀerentiation of osteoblast cells. Collectively, DOPA-containing MAP is a promising
functional binder biomaterial for xenograft bone substitute-assisted bone regeneration with enhanced
osteoconductivity and acquired osteoinductivity. This mussel glue could also be successfully utilized as a
potential biomaterial for general bone tissue engineering.Introduction
Bone is a specialized tissue that serves multiple functions, such
as structural support, protection of vital organs, and metabolic
regulation of mineral balance.1 Thus, eﬀective treatment or
replacement of osseous defects is important in bone tissue
engineering.2 Autologous gras, usually harvested from a
patient's own bone, are the ideal materials for bone substitutes
because of their osteogenic, osteoinductive, and osteo-
conductive properties.3 However, there are many barriers to the
use of autologous gras, such as limited availability, require-
ment of a second surgery, increased operation time, lack of gra
quantity, secondary infection or bleeding, chronic donor siteng University of Science and Technology,
tech.ac.kr
t of Dental Biomaterials Science, Seoul
raduate School, Seoul 136-705, Korea
Department of Dentistry, Anam Hospital,
705, Korea. E-mail: junsang@korea.ac.kr
555pain, and additional preparation cost.3 To overcome these
disadvantages of autologous gras, several bone gra substi-
tutes, such as allogras, xenogras, and alloplasts, are used as
lling materials because of their compositional similarity,
biocompatibility, and osteoconductivity.4–6 Among these bone
substitutes, xenogras are commonly used in all elds of
orthopedic and dental surgery, based on much evidence for
their suitability in in vivo applications.
Clinically, xenogra bone substitutes, such as deproteinized
bovine bone mineral (DBBM), are typically used in a hydrated
form, mixed with saline or the patient's blood, although these
substitute particles are not well agglomerated. Because xeno-
gra bone substitute particles are not well retained at the defect
site, their displacement reduces the osteoconductivity before
bone formation is properly generated. To date, diverse
approaches have been attempted to solve these problems
caused by using xenogra particles.7–12 One major approach is
to employ a physical barrier using non-resorbable materials
(e.g., titanium mesh and expanded polytetrauorethylene) or
resorbable materials (e.g., collagen membrane, polylactic acid,This journal is © The Royal Society of Chemistry 2015
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View Article Onlinepolyglycolic acid, and polyurethane).7–10 Although non-resorb-
able barrier membranes provide an eﬀective barrier function for
a suﬃcient period of time, they require a second surgery for
their removal.7,9 In contrast, resorbable barrier membranes can
be resorbed by the body; however, these membranes have
several weaknesses, such as unpredictable degradation time
and weak rigidity.7 Another approach is mixing with sticky
biomaterials, such as collagen and hyaluronic acid, without a
barrier membrane.11,12 Several reports have provided evidence
for improved bone regeneration by increasing the retention of
xenogra particles by using sticky materials. However, these
sticky materials usually lack osteoinductivity and thus should
be further investigated to prove their eﬃcacy.
Mussel adhesive proteins (MAPs) have been paid great
attention as biomaterials in tissue and biomedical engineering
because of their superior properties, including biocompatibility
and surface-independent adhesiveness, even in a wet environ-
ment.13,14 Previously, recombinant hybrid-type MAP was
designed and mass-produced in Escherichia coli to overcome the
limited availability of natural MAPs.15 This hybrid MAP is
composed of six repeats of type 1 protein (fp-1) decapeptide at
both the N- and the C-termini of type 5 protein (fp-5). In general,
the outstanding adhesive properties of MAPs are attributed to
3,4-dihydroxyphenylalanine (DOPA), which is the hydroxylated
form of tyrosine.16 Aside from its adhesive role as a protein
constituent, several reports show that the DOPA molecule
shows osteoinductive activity in vitro17–19 and in vivo.20
In the present work, we evaluated the in vivo potential of
MAP as a functional osteoinductive binder material for bone
regeneration in bone tissue engineering. We conrmed both
the binding of DOPA-containing MAP (mMAP) to DBBM parti-
cles and the eﬀects of mMAP-bound DBBM on new bone
formation in a defect in the rat calvaria. We also investigated
several in vitro cellular behaviors, such as adhesion, prolifera-
tion, spreading, and diﬀerentiation, on an mMAP-coated
surface to assess the osteoinductive ability of mMAP.Experimental
Preparation of mMAP
The expression and purication of a recombinant hybrid-type
MAP, fp-151, were performed as described in previous
studies.15,21–23 For in vitro DOPA modication, 2 g L1 of puried
original MAP was dissolved in 200 mM acetate buﬀer (pH 5.5)
with 20 mM ascorbic acid and 20 mM boric acid. Mushroom
tyrosinase (Sigma-Aldrich, St. Louis, MO) was then added to the
solution to a nal concentration of 50 mg L1. The modication
reaction was performed at room temperature for 1 h under
gentle stirring and aeration. DOPA conversion of tyrosine resi-
dues was assessed by nitroblue tetrazolium (NBT) staining and
amino acid composition analysis as followed in previous
studies.23,24 The mMAP was freeze dried for further procedures.NBT staining
Quinone-carrying quinoproteins and quinonoid substances
such as DOPA and DOPA-quinone are detectable by redox-This journal is © The Royal Society of Chemistry 2015cycling staining in the presence of NBT and glycinate at alkaline
pH. Aer gel electrophoresis of mMAP which was dissolved in
5% (vol/vol) acetic acid, the gel was transferred to a nitrocellu-
lose membrane (Protan BA83; Whatman, GE healthcare, Little
Chalfont, UK). Then, the membrane was immersed in 2 M
sodium glycinate buﬀer (pH 10) containing 0.5 mg ml1 NBT
and incubated at room temperature until a blue-purple color
developed. The stained membrane was washed with 0.2 M
sodium borate solution (pH 8.5) and DW.
Amino acid composition analysis
mMAP was hydrolyzed into amino acids using the ninhydrin
reaction. mMAP was placed in a glass vial and dissolved in a
20 : 1 mixture of 6 M HCl with phenol. The glass vial was sealed
aer being charged with Argon gas. mMAP was hydrolyzed at
156 C for 1 h, then, its hydrolysate was evaporated and washed
to remove the solvent. Aer dissolving the hydrolyzed mMAP in
a dilution buﬀer, content values of its amino acids including
DOPA were determined using an amino acid analyzer (S4300,
SYKAM, Germany) and recalculated to nd the ratio of DOPA in
mMAP.
Preparation of DBBM aggregate using mMAP binder
DBBM (Ti-Oss; Chiyewon, Guri, Korea) was used as an experi-
mental xenogra bone substitute material for in vivo bone
regeneration. mMAP powder was dissolved in endotoxin-free
distilled water (HyClone, Logan, UT) to a 300 g L1 concentra-
tion. The protein sample was stored in a vacuum-packed state
and opened at the time of its use. In total, 10 mg of DBBM
particles were mixed with 100 mL of mMAP solution to prepare
the DBBM aggregate. To investigate the morphology of osteo-
blast cells on the DBBM surface, 50 mg of mMAP per cm2 of well
area was coated to the DBBM particle using the precipitation
method as followed in a previous study.21 Then, osteoblast
MC3T3-E1 cells (RIKEN Cell Bank, Tsukuba, Japan) were seeded
on DBBM alone and on mMAP-coated DBBM samples. Aer 1
day of cultivation under serum-containing conditions, the
morphology of the osteoblast cells on the DBBM surfaces was
analyzed by scanning electron microscopy (SEM; JSM-6010LV;
JEOL Ltd., Tokyo, Japan) using 5 kV secondary electron imaging.
Animal surgery for in vivo bone regeneration
Fieen male Sprague-Dawley rats (Orient Bio Inc., Gyeonggido,
Korea) weighing 250–300 g were housed two per cage in a
facility of the specic-pathogen-free-2 (SPF-2) level, which was
covered with so bedding. The rats were allowed free access to
food and water in a temperature- and humidity-controlled room
(23 C, 50%) with a 12/12 h day/night cycle (8 am/8 pm). Aer a 7
day acclimation, each rat was anesthetized with an intramus-
cular injection of 30 mg kg1 Zoletil 50 (tiletamine and zola-
zepam; Virbac, Carros, France) and 10 mg kg1 Rompun
(xylazine; Bayer, Leverkusen, Germany), and the scalp was
incised carefully. Each exposed calvaria was then punctured in a
critical size of defect using an 8 mm-diameter trephine bur
under sterile saline irrigation, and the hole was lled with
10 mg of Ti-Oss aggregate containing 100 mL of mMAP. TheJ. Mater. Chem. B, 2015, 3, 546–555 | 547
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View Article Onlinedefect area in the negative-control (sham surgery) group was le
empty, whereas that of the DBBM group was lled with only
10 mg of Ti-Oss particles. The incised periosteum and skin were
closed in layers with 5-0 Vicryl sutures (Ethicon, Somerville, NJ)
aer the procedure. Aer the surgery, the rats were kept in their
cages for 8 weeks. To obtain calvarial samples for radiographic
and histological analyses, the rats were sacriced using the
formalin-perfusion xation method.
Radiographic and histological analyses for in vivo bone
regeneration
The rat calvarial specimens were xed with 10% formalin for
24 h. Radiographs of the specimens were then taken using X-ray
microtomography (mCT) (SkyScan 1172; Bruker-microCT, Kon-
tich, Belgium). A total of 683 slices were imaged (10.89 mm per
slice for a 590 ms exposure) for each specimen, and the pictures
were analyzed and used to generate a 3D image of 2000  1048
pixels using CT reconstruction soware (NRecon v.1.4.4;
Bruker-microCT). The regenerated bone area was quantied
using an image analysis program (CTAn v.1.6.0; Bruker-
microCT).
Aer radiographic analysis, the rat calvarial specimens were
decalcied in a decal solution (Calci-Clear Rapid; National
Diagnostics, Atlanta, GA) for 24 h. The samples were then
embedded in paraﬃn and cut into 3 mm sections. The tissue
slices were subjected to deparaﬃnization and hydration steps
and then stained with hematoxylin-eosin (H&E; Sigma-Aldrich),
Masson trichrome (MT; Sigma-Aldrich), and toluidine blue (TB;
Sigma-Aldrich). Histologic photographs were taken under a BX-
41 microscope (Olympus, Tokyo, Japan) and analyzed using
ToupView soware (ToupTek Photonics Co., Hangzhou, China).
In vitro cell attachment and proliferation analyses
Six- or 24-well polystyrene culture plates (SPL Life Sciences,
Pocheon, Korea) were used for the in vitro studies. In total, 50 mg
of MAP per cm2 of well area was used for surface coating, and
the coating method was performed according to a previous
study.21 A surface coated with PLL (Sigma-Aldrich) was used as a
comparative control, and an uncoated, bare surface was used as
a negative control. PLL was coated onto culture plates as
described in the manufacturer's instructions.
MC3T3-E1 osteoblast cells were maintained in Minimal
Essential Medium-alpha (a-MEM; HyClone) supplemented with
10% (vol/vol) fetal bovine serum (FBS; HyClone) and penicillin/
streptomycin (HyClone) at 37 C under 5% CO2 in a humid
atmosphere. The cells were subcultured using 0.05% trypsin-
ethylenediaminetetraacetic acid (trypsin-EDTA; HyClone) when
they reached 80% conuence. For cell attachment testing, 5 
104 cells (>95% viable) in serum-free medium were pipetted
onto each sample-coated 24-well culture plate. The cells were
incubated in a humidied incubator (37 C and 5% CO2) for 1 h,
allowing them to adhere to the sample-coated culture plates,
and unattached or loosely tethered cells were removed from the
surfaces using Dulbecco's modied phosphate-buﬀered saline
(DPBS; HyClone). The attached cells on the surface were further
cultured in culture medium for 72 h for a proliferation548 | J. Mater. Chem. B, 2015, 3, 546–555experiment. A Cell Counting Kit-8 (CCK-8; Dojindo Laborato-
ries, Kumamoto, Japan) was used to quantify cell attachment
and proliferation. The CCK-8 assay was performed aer the cell
attachment experiment and every 24 h for 3 days. A total of
25 mL of the CCK-8 solution was added to each well, and the
plates were further incubated for 3 h at 37 C. Aer incubation,
the formazan-containing media were transferred to a 96-well
plate (SPL Life Sciences) and measured at 450 nm using a
microplate absorbance spectrophotometer (Bio-Rad, Hercules,
CA).
In vitro cell spreading and cytoskeletal organization analyses
MC3T3-E1 cells were cultured in serum-free medium for serum
starvation before the cell spreading experiment. In total, 1 105
cells in serum-free medium were placed in a sample-coated
12 mm f cover glass (Superior Marienfeld, Lauda-Ko¨nigshofen,
Germany) and incubated for up to 18 h. FITC-conjugated
phalloidin (Sigma-Aldrich) and 40,6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) were used to stain actin laments and
nuclei, respectively. The specimens were analyzed using a
uorescence microscope (Olympus, Tokyo, Japan).
In vitro cell diﬀerentiation analyses
MC3T3-E1 cells were seeded into sample-coated 6-well plates
and cultured in the same way as in the proliferation experiment.
At 90% conuence, diﬀerentiation of the osteoblast cells was
induced by diﬀerentiation medium, which was a mixture of 50
mg mL1 ascorbic acid, 10 mM sodium phosphate monobasic,
and 1 nM dexamethasone (Sigma-Aldrich) in culture medium.
The mineralized matrix of the MC3T3-E1 cells at 21 days aer
diﬀerentiation was stained with Alizarin Red S solution
(adjusted to pH 4.2 with ammonium hydroxide; Sigma-Aldrich)
aer formaldehyde xation. Aer the removal of the Alizarin
Red S solution, the cells were rinsed three times with deionized
water. Images of the stained area were obtained using an optical
microscope (Olympus).
To evaluate osteogenic gene expression, total RNA was iso-
lated from cells at 7 days aer diﬀerentiation using the TRIzol®
reagent (Invitrogen, Carlsbad, CA) following the manufacturer's
protocol. The total RNA was quantied by absorbance readings
at 260 nm using a UV-Vis spectrophotometer (Mecasys, Dae-
jeon, Korea). Following RNA purication, rst-strand cDNA was
synthesized from 1 mg of total RNA using TOPscript™ RT Dry-
MIX (dT18) (Enzynomics, Daejeon, Korea). Real-time RT-PCR
analysis was performed using a thermocycler (LightCycler® 2.0;
Roche Applied Science, Basel, Switzerland). Samples (2  SYBR
Green Mix, 0.5 mM each appropriate primer, and cDNA) were
amplied in the thermocycler for an initial denaturation at
95 C for 15 min, followed by 40 PCR cycles. Each cycle con-
sisted of 95 C for 15 s, 60 C for 30 s, and 72 C for 30 s. The
oligonucleotide primers for the experiment are shown in Table
1.
The amplied target gene was rst detected at a specic
uorescence intensity (Ct, cycle threshold), and data were
generated by relative quantication normalized to the house-
keeping gene. Briey, 3 independently tested Ct values of theThis journal is © The Royal Society of Chemistry 2015
Table 1 Primers used in the study
Marker gene Primer sequences
GAPDH Forward 50-TTGTCTCCTGCGACTTCAACA-30
Reverse 50-GTGGTCCAGGGTTTCTTACTCC-30
Runx2 Forward 50-GACGTGCCCAGGCGTATTTC-30
Reverse 50-AAGTCTGGGGTCCGTCAAGG-30
T1Col Forward 50-GAGCGGAGAGTACTGGATCG-30
Reverse 50-GCTTCTTTTCCTTGGGGTTC-30
BSP Forward 50-TCCATCGAAGAATCAAAGCA-30
Reverse 50-ATGAGCGTGGCCGGTACTTA-30
ALP Forward 50-GCCCTCCAGATCCTGACCAA-30
Reverse 50-GCAGAGCCTGCTTGGCCTTA-30
OCN Forward 50-ACCTCACAGATGCCAAGCCC-30
Reverse 50-TCACTTGTCTGAGGCCGCGT-30
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View Article Onlinetarget gene were normalized to those of the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene for computation of
DCt, and calculation of DDCt was then performed by subtract-
ing the DCt value of the control group from that of the test
group. The fold change in target gene expression in the test
group was calculated by the comparative Ct method.25 To check
for amplication error, a melting-curve analysis (cooling the
sample to 65 C for 15 s and then heating slowly to 95 C, with
continuous measurement of uorescence) was immediately
performed at the end of each PCR.Fig. 1 (A) NBT staining and (B) amino acid composition analyses of
recombinant MAP after DOPA modiﬁcation. Lanes: MW, molecular
weight marker; MAP, unmodiﬁed MAP;mMAP, DOPA-containing MAP.Statistical analysis
In vivo data were obtained from 3 (for sham surgery) or 6 (for the
DBBM-alone and mMAP-bound DBBM groups) individual rats.
Independent in vitro experiments were performed at least 3
times, and triplicate samples were analyzed in each experiment.
The signicance of the data obtained from the control and test
groups was statistically analyzed using the one-way analysis of
variance (ANOVA) test. A p-value of <0.05 was considered
statistically signicant.Results and discussion
DOPA modication of MAP and binding of DBBM particles
using mMAP
Due to the absence of post-translational modication
machinery in an E. coli system, we performed in vitro DOPA
modication using mushroom tyrosinase. Based on the NBT
staining, we observed the appearance of a purple band for
tyrosinase-treated MAP, whereas no band was observed for the
unmodied original sample, indicating successful in vitro
DOPA modication (Fig. 1A).
To quantify the DOPA modication yield, we analyzed the
amino acid composition of mMAP using a chromatographic
method, even though the calculation of the precise yield might
have been impossible due to the hydrolysis step during sample
preparation. We determined that the in vitro percentage of
conversion (modication yield) of tyrosine residues to DOPA
molecules was 38.2% by amino acid composition analysis
(Fig. 1B).This journal is © The Royal Society of Chemistry 2015To test the binding ability of mMAP in aqueous environ-
ments, we prepared the DBBM particles and mMAP to make an
aggregate, and compared with the unmodied MAP/DBBM
aggregate. We observed that each DBBM particle was easily
agglomerated to form a large cluster in themMAP-treated group
(Fig. 2A). Moreover, the DBBM aggregate was not separated into
particles when it was lied by forceps (data not shown), indi-
cating that mMAP eﬀectively binds bone substitute particles.
Even though both aggregates of mMAP/DBBM and MAP/DBBM
had almost a similar appearance in dry environments, the MAP/
DBBM aggregate rapidly dispersed in aqueous environments
(Fig. 2A).
Next, prior to the animal experiment, in vitro osteoblast
MC3T3-E1 cell adhesion to the mMAP-applied DBBM surface
was evaluated. We found that both cell spreading on and the
population of the mMAP-applied DBBM were more extensive
than on the DBBM alone (Fig. 2B).In vivo bone regeneration using mMAP-bound DBBM
aggregates
Depending on the applied body parts, in vivo applications oen
should maintain their performance in aqueous environments
such as blood and body uid. MAP without DOPA modicationJ. Mater. Chem. B, 2015, 3, 546–555 | 549
Fig. 2 (A) Photographic images of DBBM particles, MAP-bound DBBM aggregates, and mMAP-bound DBBM aggregates in dry and aqueous
environments. (B) Morphology of osteoblast cells on the DBBM particle surface using SEM analysis. The red arrows indicate cells on the DBBM
particle surface. The scale bars represent 20 mm. Abbreviations: DBBM, DBBM alone; MAP/DBBM, MAP-bound DBBM; mMAP/DBBM, mMAP-
bound DBBM.
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View Article Onlinemay not sustain its adhesive capability during the in vivo
regeneration period. Therefore, we conducted in vivo bone
regeneration in a critical-sized rat calvarial defect model using
the mMAP-bound DBBM aggregate. A sham surgery group was
used as a negative control, and a DBBM-alone group was used as
a comparative control. The rats were sacriced aer 8 weeks of
healing for radiographic and histological analyses. Visualiza-
tion and quantication of newly formed bone in the critical-
sized rat calvarial defect were performed via a mCT system.
Although mCT is powerful technique for the assessment of
bone tissue, it is diﬃcult to distinguish a newly formed bone
from graed DBBM due to their compositional similarity.
Furthermore, it is known that DBBMs (e.g., Bio-Oss and Ti-Oss)
are hardly resorbed during the experimental period.26 There-
fore, mCT analysis was conducted based on density diﬀerences
to distinguish the newly formed bone from the graed DBBM.
Images of the transverse plane (Fig. 3A–a) and sagittal plane
(Fig. 3A–b) and a 3-dimensional (3D) bone scan (Fig. 3A–c)
showed that the defect (white dotted circle in Fig. 3A–a)
signicantly recovered, forming a new bone, in the DBBM-alone
and mMAP-bound DBBM groups.
Whereas the bone defect of the sham surgery group was only
13% repaired, the percentage of bone volume per tissue550 | J. Mater. Chem. B, 2015, 3, 546–555volume in the DBBM-alone group increased bymore than45%
during the 8 weeks of healing (Fig. 3B). Importantly, the total
amount of newly formed bone in the mMAP-bound DBBM
group signicantly increased, up to 57% (Fig. 3B). Notably, we
observed a signicant loss of DBBM particles from the detect
site in the DBBM-alone group (yellow dotted circle in Fig. 3A–a).
Therefore, from these radiographic analyses, we could conclude
that the superior in vivo bone regeneration eﬀect of mMAP was
attributable to the adhesive nature of MAP, binding DBBM
particles in the desired location (the defect site) and possibly
recruiting endogenous functional biomolecules to the surface
of the DBBM. Furthermore, interestingly, in the rat calvarial
defect site, a new bone formed more densely in the mMAP-
bound DBBM group compared with the DBBM-only group and
had a similar density to the normal bone (Fig. 3C). This result
might indicate that mMAP has an osteoinductive function in in
vivo bone maturation.
Aer quantication of bone regeneration, we evaluated the
quality of the newly formed bone by 3 staining methods: H&E,
MT, and TB staining. Similar to the results of the radiographic
analysis, a larger amount of bone formation was clearly
observed in the mMAP-bound DBBM group compared with the
DBBM-only group by H&E staining (40  magnication;This journal is © The Royal Society of Chemistry 2015
Fig. 3 Microcomputed tomography analyses of bone regeneration in a rat calvarial defect at 8 weeks post-surgery. (A) Images of a) the
transverse plane and b) sagittal plane and c) 3D analyses. In the 3D images, the blue color indicates DBBM, the white color indicates empty sites,
and the pink color indicates the newly formed bone. (B) Percentage of bone volume per tissue volume and (C) bonemineral density of the defect
site. The values and error bars represent the means of six independent animals and standard deviations, respectively, with statistical signiﬁcance
(*p < 0.05, **p < 0.01, ***p < 0.005, one-way ANOVA). Abbreviations: SS, sham surgery group; DBBM, DBBM-alone group; mMAP/DBBM,
mMAP-bound DBBM group.
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View Article OnlineFig. 4A). In high-resolution images of the MT staining (100 
magnication; Fig. 4B) and TB staining (200  magnication;
Fig. 4C), newly formed lamellar bone (yellow arrows) resulting
from osteoblastic osteoid formation and osteoid (blue arrows)
resulting from osteoblast rimming (white arrows) were detected
in the mMAP-bound DBBM group, whereas osteoid from oste-
oblast rimming was found only adjacent to the DBBM in the
DBBM-only group. Furthermore, we observed osteocytes (red
arrows) only in the mMAP-bound DBBM group (Fig. 4C). These
results indicate that the new bone created between the DBBM
particles had already formed before the eighth week of healing
and that the bone remodeling process was actively progressing
in the mMAP-bound DBBM group.
The terminology of ‘osteoinductive activity’ was originally
dened as the procedure in which osteogenesis is induced.27,28
Recently, it is considered that the osteoinduction process isThis journal is © The Royal Society of Chemistry 2015composed of 3 sequential processes; cell/active molecule
recruit, cell diﬀerentiation, and bone formation.29 We suggest
that mMAP has osteoinductive activity based on recruitment of
cells and active molecules through its unique adhesion ability
even though it does not possess autoinduction properties such
as BMP-2. Consequently, in vivo bone regeneration was accel-
erated by mMAP, and subsequently, the bone remodeling
process was stimulated in the mMAP-bound DBBM group.
Because mMAP can assist bone regeneration in both quantita-
tive and qualitative aspects in the rat calvarial defect model, it
could be successfully utilized as a functional biomaterial for
bone tissue engineering.
In vitro osteoblast cell behaviors on themMAP-coated culture
surface. Based on the in vivo bone regeneration experiments, we
found that mMAP might have osteoinductive ability. Thus, to
evaluate the potency of the osteoinductivity of mMAP, weJ. Mater. Chem. B, 2015, 3, 546–555 | 551
Fig. 4 Histological analyses of bone regeneration in a rat calvarial defect at 8 weeks post-surgery. Images of (A) H&E staining at 40 
magniﬁcation, (B) MT staining at 100 magniﬁcation, and (C) TB staining at 200 magniﬁcation. The white arrows indicate osteoblast cells, the
blue arrows indicate osteoid with osteoblastic rimming, the yellow arrows indicate newly formed lamellar bone resulting from osteoblastic
osteoid formation, and the red arrows indicate osteocytes. Abbreviations: DBBM, DBBM-alone group; mMAP/DBBM, mMAP-bound DBBM
group; NB, newly formed bone; LB, lamellar bone; OB, osteoblast cell; OI, osteoid; OC, osteocyte.
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View Article Onlineinvestigated in vitro osteoblast cell behaviors (attachment,
proliferation, spreading, and diﬀerentiation) on MAP (with or
without DOPA)-coated surfaces. An uncoated, bare surface was
used as a negative control, and a poly-L-lysine (PLL)-coated
surface was used as a positive control because the isoelectric
point (pI) (9.74) of PLL is similar to the calculated value
(9.91) for MAP.15 The rst stage in the process of cell-surface
interaction is the cell attachment, which can aﬀect subsequent
cellular responses, such as spreading, proliferation, and
diﬀerentiation.30 All cell attachment tests were performed under
serum-free conditions to minimize the eﬀects of the diverse
adhesion factors in the serum. Although cell attachment was552 | J. Mater. Chem. B, 2015, 3, 546–555slightly increased on the mMAP-coated surface compared with
that of the bare surface, there was no diﬀerence from the
unmodied MAP-coated surface (Fig. 5A).
Proliferation levels on all sample-coated surfaces showed an
at least 2-fold increase compared with the bare surface (Fig. 5B).
However, there was also no diﬀerence in osteoblast prolifera-
tion between the mMAP- and the unmodied MAP-coated
surfaces. These results might indicate that the DOPA residues in
mMAP do not contribute to cell attachment and proliferation.
Because proliferation levels on all MAP-coated surfaces were
increased (12%), regardless of DOPA existence, compared
with levels on the PLL-coated surface (Fig. 5B), we can concludeThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinethat a MAP-coated surface provides a more favorable environ-
ment for osteoblast cell proliferation through its adhesive
ability and/or accumulation of positively charged ions (e.g.,
Ca2+) on the coated surface31,32 by p-cation interaction using its
rich aromatic amino acid residues.33,34
From a morphological perspective, one of the regulating
factors for cell fate is the degree of cell spreading.35 To examine
the eﬀect of mMAP coating on cell spreading, we monitored the
morphological changes of MC3T3-E1 cells on the sample-coated
surfaces under serum-free conditions using immunocyto-
chemical analysis with uorescein isothiocyanate (FITC)-
conjugated phalloidin staining. In low-resolution spreading
images, more osteoblast cells were attached on both unmodi-
ed MAP- and mMAP-coated surfaces than in the comparative
groups (Fig. 5C). Furthermore, we observed that cell spreading
on both MAP- and mMAP-coated surfaces was more stretched
than spreading in the control groups in high-resolution images
(inset image in Fig. 5C). It is known that the cell spreading event
typically occurs through interaction of extracellular matrix
(ECM) proteins (or their specic peptides) and their recep-
tors.36,37 Several studies, however, have demonstrated that
osteoblast cell spreading can also be inuenced by immobilized
calcium ions.38,39 Because our experimental samples did not
have any activating groups for cell spreading, such as ECM
proteins or their specic peptides, we suspect that calcium ions
attached to MAP via p-cation interaction fostered a better
spreading environment than in the other control groups under
serum-depleted conditions.Fig. 5 (A) Attachment, (B) proliferation, and (C) spreading of MC3T3-E1
protein sample used for surface coating was 50 mg cm2. MC3T3-E1 cel
for 1 h for cell attachment. The viable cells attached to the surfacewerem
means of three independent experiments with triplicate samples and stan
< 0.01, ***p < 0.005, one-way ANOVA). For the spreading test, cells we
serum and cultured for 18 h. Actin ﬁlaments stained with FITC-phalloidin
bars represent 50 mm. Abbreviations: NC, bare surface; MAP, unmodiﬁed
PLL, poly-L-lysine-coated surface.
This journal is © The Royal Society of Chemistry 2015Aer the period of cell proliferation, the ECM of osteoblast
cells undergoes compositional and organizational adaptation
for mineralization.40 Although these changes are typically
induced by growth factors and hormones, especially bone
morphogenetic protein-2 (BMP-2), the diﬀerentiation of osteo-
blast cells can be also induced in DOPA-contained environ-
ments.17–20 To evaluate the eﬀect of the DOPA residues inmMAP,
we examined the diﬀerentiation of MC3T3-E1 cells on sample-
coated surfaces. Phenotypic osteoblast diﬀerentiation was
assessed by measuring the calcium deposition of the ECM of
diﬀerentiated MC3T3-E1 cells through visualization using
Alizarin Red S staining. We observed that the mineral deposi-
tion of MC3T3-E1 cells on the mMAP-coated surface was
signicantly increased compared with deposition on bare and
PLL-coated surfaces (Fig. 6A).
Althoughmineral deposition on the unmodied MAP-coated
surface was lower than that on the mMAP-coated surface, this
deposition occurred at a much higher level than in the control
groups. Thus, similar to previous results on proliferation and
spreading, we strongly suggest that the increased calcication
was seriously aﬀected by MAP via its adhesive ability and/or
electrostatic interaction. Next, genotypic diﬀerentiation was
determined by the quantication of the expression levels of
osteogenic genes, including runt-related transcription factor 2
(Runx2), type 1 collagen (T1Col), bone sialoprotein (BSP), alka-
line phosphatase (ALP), and osteocalcin (OCN), using the real-
time reverse transcription-polymerase chain reaction (RT-PCR).
We found that the expression of all of the transcription factorosteoblast cells on sample-coated surfaces. The concentration of the
ls were incubated in sample-coated 24-well polystyrene culture plates
easured by a colorimetric assay. The values and error bars represent the
dard deviations, respectively, with statistical signiﬁcance (*p < 0.05, **p
re added to a cover glass coated with 50 mg cm2 of sample without
are presented in green, and nuclei stained with DAPI are blue. The scale
MAP-coated surface;mMAP, DOPA-containing MAP-coated surface;
J. Mater. Chem. B, 2015, 3, 546–555 | 553
Fig. 6 Diﬀerentiation of MC3T3-E1 osteoblast cells on sample-coated surfaces. (A) Matrix mineralization of osteoblast cells on sample-coated
6-well polystyrene culture plates after 21 days of treatment with diﬀerentiation signals, as observed by Alizarin Red S staining. The scale bars
represent 50 mm. (B) The osteogenic gene expression of osteoblast cells was detected by real-time RT-PCR at 7 days after diﬀerentiation. The
values and error bars represent the means of triplicate samples and standard deviations, respectively, with statistical signiﬁcance (*p < 0.05, **p <
0.01, ***p < 0.005, one-way ANOVA). Abbreviations: NC, bare surface; MAP, unmodiﬁed MAP-coated surface;mMAP, DOPA-containing MAP-
coated surface; PLL, poly-L-lysine-coated surface; Runx2, runt-related transcription factor 2; T1Col, type 1 collagen; BSP, bone sialoprotein; ALP,
alkaline phosphatase; OCN, osteocalcin.
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View Article Onlineand marker genes related to osteoblast diﬀerentiation was
signicantly increased in cells on both MAP- and mMAP-coated
surfaces compared with a bare surface (Fig. 6B). Interestingly,
BSP gene expression was remarkably upregulated on themMAP-
coated surface compared with the unmodied MAP-coated
surface. Because it is known that BSP is involved in the
mineralization process of osteoblast cells and their matura-
tion,41,42 we assumed that the DOPA residues in mMAP are
closely related to the maturation of osteoblast cells. From these
results, we conclude that osteoblast diﬀerentiation can be
induced by MAP and that the eﬀect might be further enhanced
by the DOPA residues in mMAP.Conclusions
Here, we assessed mMAP as a functional osteoinductive binder
of DBBM particles for in vivo bone regeneration. DBBM particles
agglomerated to form a large cluster aer mixing with a mMAP
solution. No loss of graed DBBM particles was observed in a
rat calvarial defect during in vivo healing. New bone formation554 | J. Mater. Chem. B, 2015, 3, 546–555was signicantly improved through graing of the mMAP-
bound DBBM aggregate compared with DBBM alone (12%
increase) or the sham surgery control (44% increase). In
addition, a new mature bone that had a similar density to the
normal bone was formed. Furthermore, the bone remodeling
process was accelerated in the mMAP-bound DBBM group. The
in vitro osteogenic diﬀerentiation of osteoblast cells on the
mMAP-coated surface was upregulated overall compared with
diﬀerentiation on the unmodied MAP-coated surface. Thus,
based on the in vivo and in vitro results, we concluded that the
DOPA-containing mMAP has good osteoinductive ability. In
conclusion, mMAP can be successfully used as a functional
osteoinductive binder for bone substitute-assisted in vivo bone
regeneration and could be further utilized in other bone tissue
engineering applications.Acknowledgements
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